Skip to Content

Posts tagged with "Academia (vs. Industry)"

  • Academia (vs. Industry)

    Do Industrial Post-Doc Positions Work?

    A reader sends along this query, which I thought asked a very useful question: “. . .as a member of a growing biopharma company I am tasked with evaluating the effectiveness of industrial post-docs from both a business perspective and the post-doc’s experience. Specifically, we are considering adding one for a short-term (2yr) to add… Read More
  • Academia (vs. Industry)

    Different Worlds: A Last DHFR Paper Thought

    Inspired by a discussion with a colleague, I’m going to take one more crack at the recent discussion here about the J. Med. Chem. DHFR paper. Those of you with an interest in the topic, read on. Those whose interest has waned, or who never had much interest to start with, take heart: other topics… Read More
  • Academia (vs. Industry)

    Europe Wants Some of That Molecular Library Action

    We’ve talked about the NIH’s Molecular Libraries Initiative here a few times, mostly in the context of whether it reached its goals, and what might happen now that it looks as if it might go away completely. Does make this item a little surprising? Almost a decade ago, the US National Institutes of Health kicked… Read More
  • Academia (vs. Industry)

    Merck’s CALIBR Venture

    So the news is that Merck is now going to start its own nonprofit drug research institute in San Diego: CALIBR, the California Institute for Biomedical Research. It’ll be run by Peter Schultz of Scripps, and they’re planning to hire about 150 scientists (which is good news, anyway, since the biomedical employment picture out in… Read More
  • Academia (vs. Industry)

    Making the Move From Industry to Academia

    I have a reader who’s in the process of moving from an industrial setting to teaching medicinal chemistry. He wanted to know if I’d ever written about that topic, and I have to say, I don’t think there’s been a post dedicated to it yet. I know that many people have done just this (and… Read More
  • Academia (vs. Industry)

    More on the NIH’s Molecular Libraries Program

    I last wrote about the Molecular Libraries program here, as it was threatened with funding cuts. Now there’s a good roundup of opinion on it here, at the SLAS. The author has looked over the thoughts of the readership here, and also heard from several other relevant figures. Chris Lipinski echoes what several commenters here… Read More
  • Academia (vs. Industry)

    That Academic-Industrial Collaboration Panel

    Here’s the streaming video of the session I did at SLAS2012 on collaboration between academia and industry. I’m not sure how long it’ll be up, so if you want to see it, you probably should go ahead and check it out. A lot of people probably wish they could fast-forward (and pause) me during regular… Read More
  • Academia (vs. Industry)

    Academia and Industry, Suing Each Other

    This is not the sort of academic-industry interaction I had in mind. There’s a gigantic lawsuit underway between Agios and the Abramson Institute at the University of Pennsylvania, alleging intellectual property theft. There are plenty more details at PatentBaristas: According to the complaint filed in the US District Court Southern District… Read More
  • Academia (vs. Industry)

    Panel on Academic-Industrial Collaboration in Drug Discovery

    So, what questions should be asked? I’ve been asked to moderate a panel discussion (“Bridging the Valley of Death”) at the upcoming Society for Laboratory Automation and Screening conference in San Diego. It’s a session moderated by Bill Janzen from the University of North Carolina and Michelle Palmer from the Broad Institut… Read More
  • Academia (vs. Industry)

    Francis Collins Speaks

    With all the recent talk about the NIH’s translational research efforts, and the controversy about their drug screening efforts, this seems like a good time to note this interview with Francis Collins over at BioCentury TV. (It’s currently the lead video, but you’ll be able to find it in their “Show Guide” afterwards a… Read More
...678...